-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BSix04Lfq3JhFYnW/3POJuFjjSAf/8+mV7xZuQRhNj/gPkV8V2g2Hf/6lBbdsrpq NtS1rX8NkYKf5LBtSEUOpw== 0000736822-02-000056.txt : 20021022 0000736822-02-000056.hdr.sgml : 20021022 20021022115338 ACCESSION NUMBER: 0000736822-02-000056 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20021011 FILED AS OF DATE: 20021022 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMMUCOR INC CENTRAL INDEX KEY: 0000736822 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 222408354 STATE OF INCORPORATION: GA FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-14820 FILM NUMBER: 02794674 BUSINESS ADDRESS: STREET 1: 3130 GATWAY STREET 2: PO BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091 BUSINESS PHONE: 7704412051 MAIL ADDRESS: STREET 1: 3130 GATEWAY DR STREET 2: P O BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091-5625 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUCOR INC CENTRAL INDEX KEY: 0000736822 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] RELATIONSHIP: OFFICER IRS NUMBER: 222408354 STATE OF INCORPORATION: GA FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 4/A BUSINESS ADDRESS: STREET 1: 3130 GATWAY STREET 2: PO BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091 BUSINESS PHONE: 7704412051 MAIL ADDRESS: STREET 1: 3130 GATEWAY DR STREET 2: P O BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091-5625 4/A 1 form4apw1002.txt FORM4APW1002 October 22, 2002 Securities and Exchange Commission Washington DC 20549 Dear Sir or Madam: On behalf of Patrick Waddy, who is an Officer of Immucor, Inc. (the "Company"), we are transmitting the Statement of Changes in Beneficial Ownership on Form 4/A with respect to the Company's Common Stock. Sincerely, /s/ Edward L. Gallup Edward L. Gallup President U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4/A Statement of Changes in Beneficial Ownership Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 ___ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instructions 1(b). 1. Name and Address of Reporting Person Patrick Waddy c/o Dominion Biologicals 5 Isnor Drive Dartmouth, NS B3B 1M1 Canada 2. Issuer Name and Ticker or Trading Symbol Immucor, Inc. / BLUD 3. IRS or Social Security Number of Reporting Person (Voluntary) NA 4. Statement for Month/Year 10/11/02 5. If Amendment, Date of Original (Month/Year) 10/15/02 6. Relationship of Reporting Person to Issuer (check all applicable) Director X Officer (give title below) 10% Owner Other (specify below) President of Dominion Biologicals and European Finance Director 7. Individual or Joint/Group Filing Form filed by One Reporting Person X Form filed by More than One Reporting Person ___ TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr.3) Common Stock, $ 0.10 par value 2. Transaction Date (Month/Day/Year) A. 10/11/02 B. 10/11/02 C. 10/11/02 D. 10/11/02 E. 10/11/02 F. 10/11/02 G. 10/11/02 H. 10/11/02 I. 10/11/02 J. 10/11/02 3. Transaction Code (Instr. 8) A. X B. S C. S D. S E. S F. S G. S H. S I. S J. S 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) Amount (A) or (D) Price A. 11,250 A $6.46 B. 900 D $20.40 C. 1,250 D $20.1516 D. 2,000 D $20.20 E. 1,000 D $20.16 F. 1,000 D $20.18 G. 1,000 D $20.17 H. 1,100 D $20.15 I. 2,000 D $20.30 J. 1,000 D $20.22 5. Amount of Securities 6. Ownership Form 7. Nature of Indirect Beneficially Owned at Direct (D) or Beneficial Ownership End of Month Indirect (I) (Instr. 4) (Instr. 3 and 4) (Instr. 4) 5,000 (as previously reported) D N/A 2,500 stock split 8/26/02 D N/A ------- 7,500 balance at end of period TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) Stock Option - right to buy 2. Conversion or Exercise Price of Derivative Security $6.46 3. Transaction Date (Month/Day/Year) 10/11/02 4. Transaction Code (Instr. 8) X 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) Options as previously reported 70,500 (A) (D) N/A 11,250 6. Date Exercisable and Expiration Date (Month/Day/Year) Date Exercisable Expiration Date 7/31/00 7/31/08 7. Title and Amount of Underlying Securities (Instr. 3 and 4) Title Amount or Number of Shares NA NA 8. Price of Derivative Security (Instr. 5) NA 9. Number of Derivative Securities Beneficially Owned at End of Month (Instr. 4) 70,500 (as previously reported) 35,250 stock split 8/26/02 (11,250) shares disposed --------- 91,500 Total owned at end of month 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) D 11. Nature of Indirect Beneficial Ownership (Instr. 4) NA Explanation of Responses: /s/Patrick Waddy, by Steven C. Ramsey as Power of Attorney - ---------------------------------------------------------- Signature of Reporting Person 10/15/02 Date -----END PRIVACY-ENHANCED MESSAGE-----